332 related articles for article (PubMed ID: 34094933)
1. Immune-Related Gene SERPINE1 Is a Novel Biomarker for Diffuse Lower-Grade Gliomas
Huang X; Zhang F; He D; Ji X; Gao J; Liu W; Wang Y; Liu Q; Xin T
Front Oncol; 2021; 11():646060. PubMed ID: 34094933
[TBL] [Abstract][Full Text] [Related]
2. Screening TCGA database for prognostic genes in lower grade glioma microenvironment.
Ni J; Liu S; Qi F; Li X; Yu S; Feng J; Zheng Y
Ann Transl Med; 2020 Mar; 8(5):209. PubMed ID: 32309356
[TBL] [Abstract][Full Text] [Related]
3. Identification of tumor microenvironment-related genes in lower-grade gliomas by mining TCGA database.
Liang H; Huang C
Transl Cancer Res; 2020 Aug; 9(8):4583-4595. PubMed ID: 35117823
[TBL] [Abstract][Full Text] [Related]
4. CCR5 as a Prognostic Factor in Lower-Grade Glioma is Involved in the Remodeling of the Tumor Microenvironment.
Wang F; Tao Z; Tian Z; Jin J; Dong J; Dai Y; Yu W; Tang B; Hu S
Front Genet; 2022; 13():874896. PubMed ID: 35865011
[No Abstract] [Full Text] [Related]
5. Data mining combines bioinformatics discover immunoinfiltration-related gene SERPINE1 as a biomarker for diagnosis and prognosis of stomach adenocarcinoma.
Zhai Y; Liu X; Huang Z; Zhang J; Stalin A; Tan Y; Zhang F; Chen M; Shi R; Huang J; Wu C; Wu Z; Lu S; You L; Wu J
Sci Rep; 2023 Jan; 13(1):1373. PubMed ID: 36697459
[TBL] [Abstract][Full Text] [Related]
6. Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma.
Xu S; Wang Z; Ye J; Mei S; Zhang J
Front Oncol; 2021; 11():729103. PubMed ID: 34568059
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of γ-aminobutyric acidergic synapse-associated signature for lower-grade gliomas.
Jiang H; Sun Z; Li F; Chen Q
Front Immunol; 2022; 13():983569. PubMed ID: 36405708
[TBL] [Abstract][Full Text] [Related]
8. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
9. Molecular and Clinical Characterization of a Novel Prognostic and Immunologic Biomarker GPSM3 in Low-Grade Gliomas.
Wang M; Jia J; Cui Y; Peng Y; Jiang Y
Brain Sci; 2021 Nov; 11(11):. PubMed ID: 34827528
[No Abstract] [Full Text] [Related]
10. IRF7 as an Immune-Related Prognostic Biomarker and Associated with Tumor Microenvironment in Low-Grade Glioma.
Peng S; Wang G; Cheng Z; Guo Z
Int J Gen Med; 2021; 14():4381-4393. PubMed ID: 34413671
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Characterization of a Novel E3-Related Gene Signature With Implications in Prognosis and Immunotherapy of Low-Grade Gliomas.
Tan S; Spear R; Zhao J; Sun X; Wang P
Front Genet; 2022; 13():905047. PubMed ID: 35832194
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of the prognostic and role in immune cell infiltration of MSR1 expression in lower-grade gliomas.
Ji Q; Huang K; Jiang Y; Lei K; Tu Z; Luo H; Zhu X
Cancer Med; 2022 May; 11(9):2020-2035. PubMed ID: 35142109
[TBL] [Abstract][Full Text] [Related]
13. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
[TBL] [Abstract][Full Text] [Related]
14. A Prognostic Microenvironment-Related Immune Signature
Qiu H; Li Y; Cheng S; Li J; He C; Li J
Front Oncol; 2020; 10():580263. PubMed ID: 33425732
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Model for Lower-Grade Glioma.
Yin W; Jiang X; Tan J; Xin Z; Zhou Q; Zhan C; Fu X; Wu Z; Guo Y; Jiang Z; Ren C; Tang G
Front Oncol; 2020; 10():1409. PubMed ID: 32974146
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of age related genes in patients with lower grade glioma.
Wang H; Wang X; Xu L; Zhang J; Cao H
J Cancer; 2020; 11(13):3986-3999. PubMed ID: 32328202
[No Abstract] [Full Text] [Related]
17. Characterization of aging tumor microenvironment with drawing implications in predicting the prognosis and immunotherapy response in low-grade gliomas.
Zhou Z; Wei J; Jiang W
Sci Rep; 2022 Mar; 12(1):5457. PubMed ID: 35361903
[TBL] [Abstract][Full Text] [Related]
18. The combined signatures of telomere and immune cell landscape provide a prognostic and therapeutic biomarker in glioma.
Han X; Yan Z; Fan K; Guan X; Hu B; Li X; Ou Y; Cui B; An L; Zhang Y; Gong J
Front Immunol; 2023; 14():1220100. PubMed ID: 37662954
[TBL] [Abstract][Full Text] [Related]
19. Malignant Tumor Purity Reveals the Driven and Prognostic Role of
Lu X; Li C; Xu W; Wu Y; Wang J; Chen S; Zhang H; Huang H; Huang H; Liu W
Front Oncol; 2021; 11():676124. PubMed ID: 34557404
[TBL] [Abstract][Full Text] [Related]
20. Prognosis and immune features of pyroptosis-related RNA patterns in low-grade glioma.
Liu H; Tao T
Front Oncol; 2022; 12():1015850. PubMed ID: 36605437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
